fig5

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

Figure 5. TCGA prognostic prediction model and validation. (A) LASSO regression curve; (B) Survival curves for high- and low-risk groups. The top part shows the survival curves. The dashed line corresponds to the median survival time. The bottom part shows the risk table. The colors match the survival curves, and the table displays data on the number of surviving samples and their percentage of the total group; (C) ROC curve for 1-year survival rate prediction; (D) ROC curve for 3-year survival rate prediction; (E) ROC curve for 5-year survival rate prediction; (F) Survival curves for the validation datasets GSE70769; (G) Survival curves for the validation datasets GSE116918; (H) Survival curves for the validation datasets GSE4660. TCGA: The Cancer Genome Atlas; LASSO: least absolute shrinkage and selection operator; ROC: receiver operating characteristic.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/